Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study.
Josanne S de MaarBritt B M SuelmannManon N G J A BraatP J van DiestH H B VaessenArjen J WitkampS C LinnChrit T W MoonenElsken van der WallRoel DeckersPublished in: BMJ open (2020)
NCT03749850, EudraCT 2015-005582-23.